Diversified Growth Company - Medtech DPM CHF H
LU2304351898
Diversified Growth Company - Medtech DPM CHF H/ LU2304351898 /
NAV07/11/2024 |
Diferencia-0.1300 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
77.0200CHF |
-0.17% |
reinvestment |
Equity
Worldwide
|
NS Partners ▶ |
Estrategia de inversión
The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
The Sub-Fund will have a diversified portfolio exposed to global equity markets (Europe, North America, Asia and emerging markets). The Sub-Fund promotes social and environmental characteristics by investing at least 85% of its net assets in shares, certificates of shares and equity-like transferable securities with exposure to global equity markets that exhibit strong ESG credentials, with a specific focus on CO2 emissions.
Objetivo de inversión
The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
Datos maestros
Tipo de beneficio: |
reinvestment |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Health / Pharma |
Punto de referencia: |
MSCI World Health Care Equipment and Supplies (USD) index |
Inicio del año fiscal: |
01/01 |
Última distribución: |
- |
Banco depositario: |
UBS Europe SE, Luxembourg Branch |
País de origen: |
Luxembourg |
Permiso de distribución: |
Switzerland, Netherlands, France, Belgium, Italy, Spain, Luxembourg |
Gestor de fondo: |
NS Partners SA |
Volumen de fondo: |
25.68 millones
USD
|
Fecha de fundación: |
11/02/2022 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
3.00% |
Max. Comisión de administración: |
1.50% |
Inversión mínima: |
- CHF |
Deposit fees: |
- |
Cargo por amortización: |
0.00% |
Ongoing charges (08/02/2019): |
1.17% |
Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
Fondos de empresa: |
NS Partners |
Dirección: |
11, Boulevard de la Foire, 1528, Luxembourg |
País: |
Luxembourg |
Internet: |
www.nspgroup.com/
|
Activos
Stocks |
|
98.40% |
Cash and Other Assets |
|
1.60% |
Países
North America |
|
71.50% |
Switzerland |
|
17.20% |
Europe |
|
9.60% |
Otros |
|
1.70% |
Sucursales
Healthcare |
|
98.40% |
Cash / other assets |
|
1.60% |